Share-based Payment Arrangement, Expense of MARAVAI LIFESCIENCES HOLDINGS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MARAVAI LIFESCIENCES HOLDINGS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • MARAVAI LIFESCIENCES HOLDINGS, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $3,926,000, a 63% decline year-over-year.
  • MARAVAI LIFESCIENCES HOLDINGS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $30,174,000, a 39% decline year-over-year.
  • MARAVAI LIFESCIENCES HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2025 was $30,174,000, a 39% decline from 2024.
  • MARAVAI LIFESCIENCES HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $49,415,000, a 43% increase from 2023.
  • MARAVAI LIFESCIENCES HOLDINGS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $34,588,000, a 85% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $30,174,000 $3,926,000 -$6,619,000 -63% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $36,793,000 $9,056,000 -$3,994,000 -31% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $40,787,000 $6,789,000 -$6,974,000 -51% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $47,761,000 $10,403,000 -$1,654,000 -14% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $49,415,000 $10,545,000 +$1,203,000 +13% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $48,212,000 $13,050,000 +$3,063,000 +31% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $45,149,000 $13,763,000 +$4,491,000 +48% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $40,658,000 $12,057,000 +$6,070,000 +101% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $34,588,000 $9,342,000 +$3,347,000 +56% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $31,241,000 $9,987,000 +$5,247,000 +111% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $25,994,000 $9,272,000 +$4,964,000 +115% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $21,030,000 $5,987,000 +$2,360,000 +65% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $18,670,000 $5,995,000 +$3,765,000 +169% 01 Oct 2022 31 Dec 2022 10-K 18 Mar 2025 2024 FY
Q3 2022 $14,905,000 $4,740,000 +$1,173,000 +33% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $13,732,000 $4,308,000 +$1,925,000 +81% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $11,807,000 $3,627,000 +$1,349,000 +59% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $10,458,000 $2,230,000 -$19,466,000 -90% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $29,924,000 $3,567,000 +$1,718,000 +93% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $28,206,000 $2,383,000 +$1,807,000 +314% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $26,399,000 $2,278,000 +$1,770,000 +348% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $24,629,000 $21,696,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $1,849,000 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $576,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $508,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1

MARAVAI LIFESCIENCES HOLDINGS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $30,174,000 -$19,241,000 -39% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $49,415,000 +$14,827,000 +43% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $34,588,000 +$15,918,000 +85% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $18,670,000 +$8,212,000 +79% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2025 2024 FY
2021 $10,458,000 -$14,171,000 -58% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $24,629,000 +$22,950,000 +1367% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $1,679,000 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.